Our data suggest that strategies promoting ABCB8 function or inhibiting iron-dependent TGF-β signalling in the endothelium could be beneficial to reverse vascular inflammation in patients with cardiovascular disease, in which atherosclerosis is an underlying condition. The gene discussed is TGFB1; the disease is cardiovascular disorder.